Spinelli Coelho PL, et al. Safety of human papillomavirus 6, 11, 16 and 18
(recombinant): systematic review and meta-analysis.
Rev Paul Pediatr
.
2014;33(4).
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103- 05822015000400017
Prescrire. Human papillomavirus vaccines: 2014 safety review.
Prescrire Int
.
2015;24(160):122-9.
http://english.prescrire.org/en/81/168/49937/0/NewsDetails.aspx?page=6
Global Advisory Committee on Vaccine Safety, 2–3 December 2015.
Weekly
Epidemiol Rec
. 2016;91(3):21-32.
http://www.who.int/wer/2016/wer9103.pdf?ua=1
ANSM
. Vaccination contre les infections à HPV et risque de maladies auto-
immunes: une étude Cnamts/ANSM rassurante - Point d'information,
13/sep/2015.
http://ansm.sante.fr/S-informer/Points-d-information-Points-d- information/Vaccination-contre-les-infections-a-HPV-et-risque-de-maladies- auto-immunes-une-etude-Cnamts-ANSM-rassurante-Point-d-information
Forinash AB. Safety of the HPV Bivalent and Quadrivalent Vaccines During
Pregnancy.
Ann Pharmacother
. 2011;45(2):258-62.
http://www.ncbi.nlm.nih.gov/pubmed/21285408
Narducci A, et al. Human papillomavirus vaccine and pregnancy.
Can Fam
Physician
. 2012;58(3):268-9.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303646/